Partnering Strategy

Proximagen has a strong track record of collaborations and our commitment to partnerships continues

Our strategy for collaborations is to both “partner-in” and “partner-out”. We apply our drug discovery and development expertise to build value in programs and then seek partners for later stage development and commercialisation.

  • We are interested in preclinical small molecule programs against novel targets to feed our pipeline of programs to move into development
  • We are open to discussions on our more advanced programs with partners for later stage development and commercialization

Please contact us if you would like to discuss partnering opportunities or see the Events we will be attending